AVANTHI INC FDA Approval ANDA 203601

ANDA 203601

AVANTHI INC

FDA Drug Application

Application #203601

Application Sponsors

ANDA 203601AVANTHI INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL5MG0OXYMORPHONE HYDROCHLORIDEOXYMORPHONE HYDROCHLORIDE
002TABLET;ORAL10MG0OXYMORPHONE HYDROCHLORIDEOXYMORPHONE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2013-01-30
LABELING; LabelingSUPPL3AP2021-02-19STANDARD
REMS; REMSSUPPL5AP2018-09-18
LABELING; LabelingSUPPL8AP2021-03-04STANDARD

Submissions Property Types

ORIG1Null7
SUPPL3Null15
SUPPL5Null15
SUPPL8Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

AVANTHI INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203601
            [companyName] => AVANTHI INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"OXYMORPHONE HYDROCHLORIDE","activeIngredients":"OXYMORPHONE HYDROCHLORIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"OXYMORPHONE HYDROCHLORIDE","activeIngredients":"OXYMORPHONE HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/30\/2013","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"09\/18\/2018","submission":"SUPPL-5","supplementCategories":"REMS - PROPOSAL - D-N-A","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2018-09-18
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.